5/29/2013 9:57:24 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
HAIFA, Israel, May 29, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has been invited to present at the U.S. Food & Drug Administration's (FDA) Medical Countermeasures initiative (MCMi) which is sponsoring its 2nd annual Regulatory Science Symposium on May 29-31, 2013 at FDA headquarters in Silver Spring, Maryland.
Help employers find you! Check out all the jobs and post your resume.
comments powered by